DocGo (NASDAQ:DCGO) Posts Earnings Results

DocGo (NASDAQ:DCGO) released its quarterly earnings results on Monday. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.06), FiscalAI reports. DocGo had a negative net margin of 60.96% and a negative return on equity of 59.08%. The company had revenue of $73.43 million for the quarter, compared to the consensus estimate of $76.96 million.

Here are the key takeaways from DocGo’s conference call:

• Third-quarter revenue was $73.4 million, up 4% year over year, while the adjusted EBITDA loss narrowed to $3.2 million from $7.2 million a year earlier and $6.3 million in the prior quarter.
• DocGo lowered its 2026 revenue outlook to approximately $300 million from $305 million–$310 million, while reaffirming its adjusted EBITDA loss guidance of $17 million–$22 million. Management attributed the revenue reduction partly to exiting or restructuring unprofitable business.
• Gross margin rose to 33.3% from 30.5% in the second quarter, and adjusted SG&A declined to $28.7 million. Management cited cost cuts and AI-enabled outreach, which it said reduced cost per booking by more than 50%.
• Cash was $19.1 million at quarter-end, down from $25.2 million at the end of Q2. A $12.5 million term-loan tranche closed after quarter-end, with additional funding dependent on the Hicuity transaction and revenue conditions; the company is also pursuing collection of about $19 million in receivables.
• CEO Lee Bienstock plans to transition out once a successor is appointed and expects to remain through at least March 31, 2027. Management did not provide formal 2027 guidance, but said it anticipates revenue growth and positive adjusted EBITDA for the year.

DocGo Price Performance

NASDAQ DCGO traded up $0.01 on Wednesday, reaching $0.24. The company had a trading volume of 1,194,316 shares, compared to its average volume of 856,721. The firm has a market capitalization of $23.55 million, a PE ratio of -0.13 and a beta of 1.03. The firm has a 50-day moving average of $0.32 and a 200-day moving average of $0.55. DocGo has a 1 year low of $0.21 and a 1 year high of $1.11.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Canaccord Genuity Group restated a “hold” rating and issued a $1.00 price target on shares of DocGo in a report on Tuesday, August 18th. Needham & Company LLC reduced their target price on shares of DocGo to $1.00 and set a “buy” rating for the company in a research report on Tuesday. Finally, Weiss Ratings downgraded DocGo from a “sell (e+)” rating to a “sell (e)” rating in a research report on Tuesday. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $1.50.

DocGo Company Profile

DocGo Inc. (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care. The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination. DocGo also offers remote patient monitoring and other technology-enabled services designed to support patients between healthcare visits and help manage ongoing conditions.